Bacopa Monnieri
Also known as: Brahmi, Water Hyssop, Bacopa monnieri Wettst., CDRI 08, Bacoside-A
Effective Dosage
300-600 mg daily (higher doses may be needed for memory benefits)
What the Science Says
Bacopa monnieri is a plant used in traditional Ayurvedic medicine, primarily for brain health. Clinical trials suggest it may improve working memory, attention, and executive function in adults, with higher doses (600 mg+) showing stronger effects on memory than lower doses or Ginkgo biloba. It also shows consistent signals for reducing stress and mental fatigue, though cognitive benefits typically require at least 8–12 weeks of daily use.
What It Doesn't Do
Won't sharpen your focus overnight — effects take months to appear. Doesn't reliably improve all cognitive domains; attention and processing speed show weak or no benefit in several trials. Not proven to prevent or reverse dementia. No solid evidence it improves sleep quality. Doesn't work like a stimulant or provide immediate mental energy.
Evidence-Based Benefits
Bacopa monnieri shows modest evidence for improving certain cognitive domains, particularly attention, verbal fluency, and executive function in older adults and those with mild cognitive impairment (PMID: 38538390, PMID: 41678913). A network meta-analysis found high-dose Brahmi (≥600 mg/day) significantly improved working memory and short-term memory compared to placebo and Ginkgo biloba (PMID: 41678913). Secondary benefits including stress reduction and anti-fatigue effects after cognitively demanding tasks have also been observed (PMID: 41091332).
Moderate EvidenceEffective at: 300-600 mg/day (higher doses may be needed for working memory; no firmly established optimal dose from provided studies)
Source: auto-research
Absorption & Bioavailability
Unknown — no pharmacokinetic data in the provided studies. Standardized extracts (e.g., CDRI 08, Bacumen) are used in trials, suggesting raw herb potency may vary.
Red Flags to Watch For
- Digestive side effects (nausea, cramping, diarrhea) and headaches reported more frequently than placebo in clinical trials
- Many products on the market (891 registered in NIH DSLD) vary widely in extract standardization — look for products specifying bacoside content
- Results are inconsistent across trials — some well-designed RCTs show no significant cognitive improvement vs. placebo
- Most positive memory findings come from network meta-analyses, not direct head-to-head trials, which limits certainty
- Anti-cancer and anti-seizure claims are based only on lab (in silico or cell) studies — no human evidence provided
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-06